| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $134.5M | -5.4% |
| Cost of Revenue | $28.3M | -13.2% |
| R&D Expense | $13.6M | -24.0% |
| SG&A Expense | $37.8M | -13.8% |
| Operating Income | $238K | +100.9% |
| Pre-tax Income | $997K | +103.6% |
| Income Tax | -$20.9M | -304.9% |
| Net Income | $21.9M | +198.5% |
| EPS (Basic) | $1.11 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $35.8M | -19.8% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $26.9M | -0.2% |
| Current Assets | $70.1M | -25.5% |
| Total Assets | $244.5M | -1.5% |
| Current Liabilities | $53.5M | -2.8% |
| Total Liabilities | $72.4M | -2.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $6.5M | -19.0% |
| Capital Expenditures | $3.8M | -14.0% |
| Investing Cash Flow | $11.3M | +5103.1% |
| Financing Cash Flow | -$26.2M | -123.1% |
| Free Cash Flow | $2.7M | -25.0% |
| +197.4% |
| EPS (Diluted) | $1.09 | +195.6% |
| Stockholders' Equity |
| $172.1M |
| -0.9% |